Cannabis companies unite to help combat COVID-19
Speaking with Finfeed today about the recent volatility of the cannabis sector, its comeback, and how companies such as Canada’s WeedMD are pivoting to help the broader health sector as COVID-19 continues to put lives in danger is WeedMD CEO George Scorsis.
Scorsis is formerly President of Red Bull Canada and was instrumental in restructuring the organisation from a geographical and operational perspective, growing the business to $150M in revenue.
He was the President at Mettrum Health Corp., a leading Canadian cannabis distributor which was sold to Canopy Growth for $430 million, and before becoming WeedMD CEO, Scorsis held the role of CEO and Director of Liberty Health Sciences, an industry leader in the medical cannabis space.
About WeedMD
WeedMD is a Health Canada Licensed Producer under the Cannabis Act and its team of knowledgeable professionals are committed to providing physicians and clients the resources and guidance needed to customise the best medical cannabis treatment plan.
Where to invest $1,000 right now
When the experts at Next Investors have a stock pick, it may pay to listen.
The Next Investors have been investing in ASX small cap stocks for years, with their best small cap picks yielding returns of 1,200%, 1,120%, 900% and 678%.
They have just revealed their hand-picked, FY2021 stock portfolio of high conviction long-term investments.
Click the link below to see what they are currently investing in.
Like this article? You may like...
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
Publishers Notice
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.
